SCHEMBL18379170

SCHEMBL18379170

CCCCCCCCCCCCN1C(=O)c2ccc3c4ccc5c6c(ccc(c7ccc(c2c37)C1=O)c64)C(=O)N(Cc1ccc(N2CCOCC2)cc1)C5=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 3/20 0.46
▸ HDAC3 O15379 3/20 0.46
▸ HDAC1 Q13547 3/20 0.46
▸ HDAC2 Q92769 2/20 0.46
▸ TERT O14746 3/20 0.44
▸ STAT3 P40763 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ HDAC8 Q9BY41 2/20 0.43
▸ HDAC11 Q96DB2 2/20 0.43
▸ NCOR2 Q9Y618 2/20 0.43
▸ ADRA1D P25100 2/20 0.41
▸ ADRA1A P35348 2/20 0.41
▸ ADRA1B P35368 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HTR1A P08908 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18379065 0.92 TERT (0.51) TERTSTAT3HIF1AADRA1DADRA1A
SCHEMBL23425475 0.86 HDAC6 (0.43) HDAC6HDAC3HDAC1HDAC2TERT
SCHEMBL18379138 0.81 TERT (0.53) TERTSTAT3HIF1AMAPTKDM4E
SCHEMBL18379080 0.80 TERT (0.47) TERTSTAT3HIF1AMEN1KMT2A
SCHEMBL18379167 0.79 STAT3 (0.54) TERTSTAT3HIF1AMAPTKDM4E
SCHEMBL23957079 0.79 STAT3 (0.48) HDAC6HDAC3HDAC1HDAC2TERT
SCHEMBL18379137 0.79 STAT3 (0.65) TERTSTAT3HIF1AMAPTKDM4E
SCHEMBL8071104 0.79 STAT3 (0.65) TERTSTAT3HIF1AMAPTKDM4E
SCHEMBL1105114 0.79 STAT3 (0.65) TERTSTAT3HIF1AMAPTKDM4E
SCHEMBL418871 0.79 STAT3 (0.65) TERTSTAT3HIF1AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180201612-A1 SENSOR COMPOUNDS AND ASSOCIATED METHODS AND DEVICES UNIVERSITY OF UTAH 2018-07-19 — — US disclosed
US-20180201612-A1 SENSOR COMPOUNDS AND ASSOCIATED METHODS AND DEVICES UNIVERSITY OF UTAH 2018-07-19 — — US disclosed
WO-2017142609-A2 CHEMICAL SELF-DOPING OF ONE-DIMENSIONAL ORGANIC NANOMATERIALS FOR HIGH CONDUCTIVITY APPLICATION IN CHEMIRESISTIVE SENSING GAS OR VAPOR UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-08-24 — — WO disclosed
US-20170160252-A1 CHEMICAL SELF-DOPING OF ONE-DIMENSIONAL ORGANIC NANOMATERIALS FOR HIGH CONDUCTIVITY APPLICATION IN CHEMIRSISTIVE SENSING GAS OR VAPOR UNIVERSITY OF UTAH 2017-06-08 — — US disclosed
US-20170160252-A1 CHEMICAL SELF-DOPING OF ONE-DIMENSIONAL ORGANIC NANOMATERIALS FOR HIGH CONDUCTIVITY APPLICATION IN CHEMIRSISTIVE SENSING GAS OR VAPOR UNIVERSITY OF UTAH 2017-06-08 — — US disclosed
WO-2017008074-A1 SENSOR COMPOUNDS AND ASSOCIATED METHODS AND DEVICES UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-01-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170160252-A1 CHEMICAL SELF-DOPING OF ONE-DIMENSIONAL ORGANIC NANOMATERIALS FOR HIGH CONDUCTIVITY APPLICATION IN CHEMIRSISTIVE SENSING GAS OR VAPOR DRD1, DRD4, DNER HDAC6 4228/4885HDAC3 4615/4885HDAC1 3081/4885
US-20180201612-A1 SENSOR COMPOUNDS AND ASSOCIATED METHODS AND DEVICES NCS1, DAXX, CNDP2 HDAC6 3762/4885HDAC3 3671/4885HDAC1 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback